Ieq Capital LLC Boosts Stock Position in Healthpeak Properties, Inc. (NYSE:DOC)

Ieq Capital LLC increased its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 3.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 51,828 shares of the real estate investment trust’s stock after purchasing an additional 1,674 shares during the quarter. Ieq Capital LLC’s holdings in Healthpeak Properties were worth $1,051,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. State Street Corp bought a new position in Healthpeak Properties in the 3rd quarter worth about $1,093,576,000. Geode Capital Management LLC bought a new position in shares of Healthpeak Properties in the third quarter valued at approximately $403,898,000. Principal Financial Group Inc. boosted its position in shares of Healthpeak Properties by 2,113.5% in the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock valued at $367,575,000 after acquiring an additional 17,314,572 shares during the period. Charles Schwab Investment Management Inc. purchased a new position in Healthpeak Properties during the third quarter valued at approximately $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $175,697,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Performance

NYSE DOC opened at $19.83 on Tuesday. The firm has a market cap of $13.87 billion, a price-to-earnings ratio of 56.64, a PEG ratio of 2.17 and a beta of 1.15. The company has a 50-day simple moving average of $20.19 and a two-hundred day simple moving average of $21.38. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a 12-month low of $16.01 and a 12-month high of $23.26.

Healthpeak Properties Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th will be paid a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.15%. The ex-dividend date is Friday, February 14th. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s dividend payout ratio is 348.57%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on DOC. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a research report on Wednesday, January 15th. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Wedbush lowered their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, February 14th. Mizuho cut their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Finally, Wells Fargo & Company decreased their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.00.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.